Frontostriatal activation in patients with obsessive–compulsive disorder before and after cognitive behavioral therapy

Background Cognitive behavioral therapy (CBT) with exposure and response prevention (ERP) is the psychotherapeutic treatment of choice for obsessive–compulsive disorder (OCD). However, little is known about the impact of CBT on frontostriatal dysfunctioning, known to be the neuronal correlate of OCD. Method A probabilistic reversal learning (RL) task probing adaptive strategy switching capabilities was used in 10 unmedicated patients with OCD and 10 healthy controls during an event-related functional magnetic resonance imaging (fMRI) experiment. Patients were scanned before and after intensive CBT, controls twice at comparable intervals. Results Strategy change within the RL task involved activity in a broad frontal network in patients and controls. No significant differences between the groups or in group by time interactions were detected in a whole-brain analysis corrected for multiple comparisons. However, a reanalysis with a more lenient threshold revealed decreased responsiveness of the orbitofrontal cortex and right putamen during strategy change before treatment in patients compared with healthy subjects. A group by time effect was found in the caudate nucleus, demonstrating increased activity for patients over the course of time. Patients with greater clinical improvement, reflected by greater reductions in Yale–Brown Obsessive Compulsive Scale (YBOCS) scores, showed more stable activation in the pallidum. Conclusions Although these findings are preliminary and need to be replicated in larger samples, they indicate a possible influence of psychotherapy on brain activity in core regions that have been shown to be directly involved both in acquisition of behavioral rules and stereotypes and in the pathophysiology of OCD, the caudate nucleus and the pallidum.

[1]  V. Glauche,et al.  Test–retest reliability of event-related functional MRI in a probabilistic reversal learning task , 2009, Psychiatry Research: Neuroimaging.

[2]  H. Uylings,et al.  Differential frontal–striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive–compulsive disorder , 2009, Psychological Medicine.

[3]  E. Bullmore,et al.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited , 2008, Neuroscience & Biobehavioral Reviews.

[4]  Trevor W Robbins,et al.  Lesions of the Medial Striatum in Monkeys Produce Perseverative Impairments during Reversal Learning Similar to Those Produced by Lesions of the Orbitofrontal Cortex , 2008, The Journal of Neuroscience.

[5]  R. DeRubeis,et al.  Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms , 2008, Nature Reviews Neuroscience.

[6]  J. Grafman,et al.  A psychological and neuroanatomical model of obsessive-compulsive disorder. , 2008, The Journal of neuropsychiatry and clinical neurosciences.

[7]  B. Peterson,et al.  The neural bases of obsessive–compulsive disorder in children and adults , 2008, Development and Psychopathology.

[8]  T. Yoshiura,et al.  Functional MRI study of brain activation alterations in patients with obsessive–compulsive disorder after symptom improvement , 2008, Psychiatry Research: Neuroimaging.

[9]  T. Robbins,et al.  Orbitofrontal Dysfunction in Patients with Obsessive-Compulsive Disorder and Their Unaffected Relatives , 2008, Science.

[10]  U. Voderholzer,et al.  Reversal learning as a neuropsychological indicator for the neuropathology of obsessive compulsive disorder? A behavioral study. , 2008, The Journal of neuropsychiatry and clinical neurosciences.

[11]  T. Robbins,et al.  Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific. , 2006, Cerebral cortex.

[12]  H. Uylings,et al.  Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. , 2006, Archives of general psychiatry.

[13]  D. Linden,et al.  How psychotherapy changes the brain – the contribution of functional neuroimaging , 2006, Molecular Psychiatry.

[14]  J. Abramowitz The Psychological Treatment of Obsessive—Compulsive Disorder , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[15]  M. Frank,et al.  Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. , 2006, Psychological review.

[16]  T. Yoshiura,et al.  Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study , 2005, Biological Psychiatry.

[17]  Henk J Groenewegen,et al.  Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. , 2005, Archives of general psychiatry.

[18]  H. Westenberg,et al.  Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine , 2005, Psychiatry Research: Neuroimaging.

[19]  M. Kozak,et al.  Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. , 2007, The American journal of psychiatry.

[20]  S. Whiteside,et al.  A meta–analysis of functional neuroimaging in obsessive–compulsive disorder , 2004, Psychiatry Research: Neuroimaging.

[21]  Michael D Rugg,et al.  Remembrance of Odors Past Human Olfactory Cortex in Cross-Modal Recognition Memory , 2004, Neuron.

[22]  M. Iwakiri,et al.  Effects of behavior therapy on regional cerebral blood flow in obsessive–compulsive disorder , 2003, Psychiatry Research: Neuroimaging.

[23]  T. Robbins,et al.  Defining the Neural Mechanisms of Probabilistic Reversal Learning Using Event-Related Functional Magnetic Resonance Imaging , 2002, The Journal of Neuroscience.

[24]  S. Alborzian,et al.  Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder , 1999, Neuropsychopharmacology.

[25]  J. Aldenhoff,et al.  Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo , 1998, British Journal of Psychiatry.

[26]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[27]  R. Turner,et al.  Characterizing Evoked Hemodynamics with fMRI , 1995, NeuroImage.

[28]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[29]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[30]  J. Mazziotta,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. , 1987, Archives of general psychiatry.

[31]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.